Open AccessP1084: CHECK‐POINT INHIBITORS IN PATIENTS WITH RELAPSE/REFRACTORY HODGKIN'S LYMPHOMA: A RETROSPECTIVE ANALYSYS BY THE RETE EMATOLOGICA PUGLIESE (REP).
Author(s) -
Gaudio F.,
Loseto G.,
Bozzoli V.,
Scalzulli P. R.,
Mazzone A. M.,
Tonialini L.,
Fesce V.,
Quintana G.,
De santis G.,
Masciopinto P.,
Arcuti E.,
Clemente F.,
Scardino S.,
Tarantini G.,
Pastore D.,
Melillo L.,
Pavone V.,
Mazza P.,
Carella A. M.,
Cascavilla N.,
Di Renzo N.,
Guarini A.,
Musto P.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847204.45147.68
Subject(s) - medicine , refractory (planetary science) , brentuximab vedotin , nivolumab , oncology , salvage therapy , pembrolizumab , lymphoma , chemotherapy , surgery , immunotherapy , cancer , cd30 , physics , astrobiology